Research and Development of Traditional Medicines in Low- and Middle-Income Countries: A Case Study of Artemisinin Discovery in China.

Guang-qi Liu,Yan Xie,Yi-nuo Sun,Kai-xuan Zhang,Ji-yan Maa,Yang-mu Huang
DOI: https://doi.org/10.1016/bs.apar.2022.01.002
2022-01-01
Abstract:Though traditional medicines have been developed through practice for thousands of years, limited research has discussed the research and development (R&D) pattern of traditional medicines. China's discovery of artemisinin accumulated valuable experiences to explore traditional medicine under low-resource settings. With limited R&D resources, China mobilized all domestic research units at different levels and departments to develop artemisinin collaboratively. The discovery of artemisinin not only based on valuable experiential wisdom of traditional medicine, but also relied on excellent synergy among all units. In this study, we reviewed the story of how artemisinin was discovered in China, summarized key factors for new drug development from traditional medicines under limited resources, and raised suggestions to utilize traditional medicines in low- and middle-income countries. This case suggested that the vitality of traditional medicine could be extended by promoting new drug development based on modern methods and collaboration.
What problem does this paper attempt to address?